Famciclovir Patent Expiration

Famciclovir is Used for treating shingles infections. It was first introduced by Novartis Pharmaceuticals Corp in its drug Famvir on Jun 29, 1994. 9 different companies have introduced drugs containing Famciclovir.


Famciclovir Patents

Given below is the list of patents protecting Famciclovir, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Famvir US5840763 Treatment of a latent infection of herpes viruses Sep 01, 2015

(Expired)

Novartis
Famvir US5840763

(Pediatric)

Treatment of a latent infection of herpes viruses Mar 01, 2016

(Expired)

Novartis
Famvir US5866581 Penciclovir for the treatment of post therapeutic neuralgia Oct 04, 2014

(Expired)

Novartis
Famvir US5866581

(Pediatric)

Penciclovir for the treatment of post therapeutic neuralgia Apr 04, 2015

(Expired)

Novartis
Famvir US5916893 Treatment of a latent infection of herpes virus Sep 01, 2015

(Expired)

Novartis
Famvir US5916893

(Pediatric)

Treatment of a latent infection of herpes virus Mar 01, 2016

(Expired)

Novartis
Famvir US6124304 Penciclovir for the treatment of zoster associated pain Oct 04, 2014

(Expired)

Novartis
Famvir US6124304

(Pediatric)

Penciclovir for the treatment of zoster associated pain Apr 04, 2015

(Expired)

Novartis



Famciclovir Generics

Several generic applications have been filed for Famciclovir. The first generic version for Famciclovir was by Teva Pharmaceuticals Usa and was approved on Aug 24, 2007. And the latest generic version is by Hetero Labs Ltd Unit V and was approved on Sep 10, 2014.

Given below is the list of companies who have filed for Famciclovir generic.


1. APOTEX

Apotex Inc has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
125MG tablet Prescription ORAL AB Jul 22, 2011
250MG tablet Prescription ORAL AB Jul 22, 2011
500MG tablet Prescription ORAL AB Jul 22, 2011


2. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
125MG tablet Prescription ORAL AB Mar 21, 2011
500MG tablet Prescription ORAL AB Mar 21, 2011
250MG tablet Prescription ORAL AB Mar 21, 2011


3. CIPLA

Cipla Ltd has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
125MG tablet Discontinued ORAL N/A Mar 21, 2011
250MG tablet Discontinued ORAL N/A Mar 21, 2011
500MG tablet Discontinued ORAL N/A Mar 21, 2011


4. HETERO LABS LTD V

Hetero Labs Ltd Unit V has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.

Strength Dosage Form Availability Application Pathway TE code Launch Date
125MG tablet Prescription ORAL AB Sep 10, 2014
250MG tablet Prescription ORAL AB Sep 10, 2014
500MG tablet Prescription ORAL AB Sep 10, 2014


5. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG tablet Discontinued ORAL N/A Mar 21, 2011
125MG tablet Discontinued ORAL N/A Mar 21, 2011
250MG tablet Discontinued ORAL N/A Mar 21, 2011


6. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG tablet Prescription ORAL AB Jan 12, 2012
250MG tablet Prescription ORAL AB Jan 12, 2012
125MG tablet Prescription ORAL AB Jan 12, 2012


7. MYLAN

Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG tablet Discontinued ORAL N/A Mar 24, 2011
250MG tablet Discontinued ORAL N/A Mar 24, 2011
125MG tablet Discontinued ORAL N/A Mar 24, 2011


8. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 3 different strengths of generic version for Famciclovir. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG tablet Prescription ORAL AB Aug 24, 2007
500MG

(reference standard)

tablet Prescription ORAL AB Aug 24, 2007
125MG tablet Prescription ORAL AB Aug 24, 2007